Financial News

Since February 2016, the shares of BRAIN Biotech AG are listed in the Prime Standard segment of the Frankfurt stock exchange. As a stock-listed company in the regulated market, we are subject to a number of legal and exchange regulated publication and transparency requirements. Beyond those statutory requirements, we want to provide ongoing and comprehensive information to all our shareholders. Below you can find our different categories of financial news.

Filter Financial News:

Share this page